Search results for "Bipolar"

showing 10 items of 395 documents

Neurocognitive dysfunction in bipolar disorder

2013

Pediatricsmedicine.medical_specialtyNeurocognitive Dysfunctionbusiness.industrymedicineBipolar disordermedicine.diseasebusinessClinical Management of Bipolar Disorder
researchProduct

A clinical staging model for bipolar disorder: longitudinal approach

2020

AbstractBipolar disorder (BD) has been identified as a life-course illness with different clinical manifestations from an at-risk to a late stage, supporting the assumption that it would benefit from a staging model. In a previous study, we used a clustering approach to stratify 224 patients with a diagnosis of BD into five clusters based on clinical characteristics, functioning, cognition, general health, and health-related quality of life. This study was design to test the construct validity of our previously developed k-means clustering model and to confirm its longitudinal validity over a span of 3 years. Of the 224 patients included at baseline who were used to develop our model, 129 (…

Pediatricsmedicine.medical_specialtyScientific communityBipolar DisorderMEDLINEArticlelcsh:RC321-57103 medical and health sciencesCellular and Molecular NeuroscienceCognition0302 clinical medicineQuality of lifeHuman behaviourmedicineHumansQUALITYBipolar disorderStage (cooking)lcsh:Neurosciences. Biological psychiatry. NeuropsychiatrySalut mentalBiological Psychiatrybusiness.industryMEMORYLate stageConstruct validityCognitionmedicine.diseaseDEPRESSION030227 psychiatryPsychiatry and Mental healthSPANISH VERSIONSRELIABILITYDisease ProgressionQuality of LifeConstruct (philosophy)businessMalalties mentals030217 neurology & neurosurgery
researchProduct

Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder

2021

Abstract Introduction Bipolar disorder (BD) has been reconceptualised as a progressive disorder that develops from mild to severe presentations. An empirical staging model – the Empirically Developed Clinical Staging Model for BD (EmDe-5) – was developed in a previous study. This study aims to further validate that model using a larger and more representative Spanish sample. Material and methods 183 BD outpatients were recruited at 11 sites in Spain. Assessment included clinical characteristics of the BD (number of hospitalisations, number of suicide attempts, comorbid personality disorders), physical health (BMI, metabolic syndrome, number of physical illnesses), cognition (SCIP), function…

Pediatricsmedicine.medical_specialtybusiness.industrymedia_common.quotation_subjectConstruct validityCognitionmedicine.diseasePersonality disordersPsychiatry and Mental healthQuality of lifeProgressive disorderMedicinePersonalityBipolar disorderStage (cooking)businessmedia_commonRevista de Psiquiatría y Salud Mental
researchProduct

Correction: Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals

2019

Fronto-limbic white matter (WM) abnormalities are assumed to lie at the heart of the pathophysiology of bipolar disorder (BD); however, diffusion tensor imaging (DTI) studies have reported heterogeneous results and it is not clear how the clinical heterogeneity is related to the observed differences. This study aimed to identify WM abnormalities that differentiate patients with BD from healthy controls (HC) in the largest DTI dataset of patients with BD to date, collected via the ENIGMA network. We gathered individual tensor-derived regional metrics from 26 cohorts leading to a sample size of N = 3033 (1482 BD and 1551 HC). Mean fractional anisotropy (FA) from 43 regions of interest (ROI) a…

PharmacologyAdultMaleBipolar DisorderCorrectionBrainDiagnostic markersBiologyTranslational researchmedicine.diseaseMega-White MatterCorpus CallosumWhite matterPsychiatry and Mental healthmedicine.anatomical_structureDiffusion Tensor ImagingNeural PathwaysmedicineHumansFemaleBipolar disorderClinical psychologyNeuropsychopharmacology
researchProduct

Diet and Neurocognition in Mood Disorders - an Overview of the Overlooked.

2019

Bipolar disorder and major depression are associated with significant disability, morbidity, and reduced life expectancy. People with mood disorders have shown higher ratios of unhealthy lifestyle choices, including poor diet quality and suboptimal nutrition. Diet and nutrition impact on brain /mental health, but cognitive outcomes have been less researched in psychiatric disorders. Neurocognitive dysfunction is a major driver of social dysfunction and a therapeutic target in mood disorders, although effective cognitive-enhancers are currently lacking. This narrative review aimed to assess the potential cognitive benefits of dietary and nutritional interventions in subjects diagnosed with m…

PharmacologyBipolar Disorderbusiness.industryMood DisordersCognitionPrecision medicinemedicine.diseaseMental health030227 psychiatryDietGastrointestinal MicrobiomeClinical trial03 medical and health sciences0302 clinical medicineMood disordersDrug DiscoverymedicineHumansBipolar disorderbusinessCognition DisordersNeurocognitive030217 neurology & neurosurgeryDepression (differential diagnoses)Clinical psychology
researchProduct

Are Polygenic Risk Scores for Major Mental Disorders Associated with General or Specific Psychosis Symptom dimensions?

2019

Background Psychotic symptoms can be conceptualised as dimensions of psychopathology cutting across diagnostic boundaries. Thus, they might be considered enhanced quantitative phenotypes to relate to genetic variants as summarised by Polygenic Risk Scores (PRSs) for Major Mental Disorders (MMDs), including Schizophrenia (SZ), Bipolar Disorder (BP), and Major Depressive Disorder (MDD). The objectives of this study were to: 1) identify the dimensional structure of symptoms at First Episode Psychosis (FEP), testing whether a bi-factor model statistically fits the conceptualization of psychosis as a single common construct (general psychosis factor) while also recognising multidimensionality (p…

PharmacologyPsychosisOdds ratiomedicine.diseasePopulation stratificationschizophrenia poligenic risk scorePsychiatry and Mental healthNeurologySchizophreniamedicineMajor depressive disorderPharmacology (medical)Neurology (clinical)Bipolar disordermedicine.symptomPsychologyManiaSettore MED/25 - PsichiatriaBiological PsychiatryPsychopathologyClinical psychology
researchProduct

A MULTI-LEVEL FUNCTIONAL STUDY OF A SNAP25 AT-RISK VARIANT FOR BIPOLAR DISORDER AND SCHIZOPHRENIA

2019

Background The synaptosomal associated protein SNAP25 is crucial for synaptic vesicle docking and fusion and has been associated with multiple psychiatric conditions. We recently identified a promoter variant in SNAP25, rs6039769, associated with bipolar disorder and gene expression in prefrontal cortex. Methods Here, we performed a genetic association study using this variation on two independent cohorts of 288 and 173 subjects with schizophrenia and 315 unaffected control individuals. We replicated our results using data from the schizophrenia group of the Psychiatric Genomics Consortium (PGC). Functional consequences combined both in vitro and post-mortem gene expression analysis on 30 p…

Pharmacologymedicine.diagnostic_testbusiness.industryImaging geneticsSNAP25medicine.diseaseBioinformaticsPsychiatry and Mental healthNeurologySynaptic vesicle dockingMedicinePharmacology (medical)Neurology (clinical)Bipolar disorderAllelebusinessFunctional magnetic resonance imagingPrefrontal cortexBiological PsychiatryGenetic associationEuropean Neuropsychopharmacology
researchProduct

Neurocognitive Impairment Across the Bipolar Spectrum

2011

Bipolar disorder is a severe mental illness that affects nearly 4.4% of the general population when bipolar spectrum disorders are taken into account. Neurocognitive impairment is thought to be a core deficit of this illness since it is present during euthymia. In fact, 40–60% of euthymic patients present with neurocognitive disturbances. Not only the clinical factors but also disturbances in neurocognition can influence the functional outcome of BD patients. Hence, further research is needed in order to clarify the relationship between these variables. Despite the growing body of evidence that has emerged during the last decade, no unique neurocognitive profile has been proposed yet for ei…

Pharmacologymedicine.medical_specialtyeducation.field_of_studyBipolar Disordermedicine.diagnostic_testPopulationNeuropsychological Testsmedicine.diseaseMental illnessPsychiatry and Mental healthPhysiology (medical)medicineHumansPharmacology (medical)Bipolar disorderNeuropsychological assessmentCognition DisordersPsychologyPsychiatryeducationReviews (Special Issue for Bipolar Disorder)NeurocognitiveClinical psychologyCNS Neuroscience & Therapeutics
researchProduct

Can we use time-resolved measurements to get Steady-State Transport data for Halide perovskites?

2018

Time-resolved, pulsed excitation methods are widely used to deduce optoelectronic properties of semiconductors, including now also Halide Perovskites (HaPs), especially transport properties. However, as yet, no evaluation of their amenability and justification for the use of the results for the above-noted purposes has been reported. To check if we can learn from pulsed measurement results about steady-state phototransport properties, we show here that, although pulsed measurements can be useful to extract information on the recombination kinetics of HaPs, great care should be taken. One issue is that no changes in the material are induced during or as a result of the excitation, and anothe…

PhotoluminescenceSteady stateMaterials scienceAmbipolar diffusionbusiness.industryPhotoconductivityGeneral Physics and AstronomyFOS: Physical sciencesPhysics - Applied Physics02 engineering and technologyApplied Physics (physics.app-ph)010402 general chemistry021001 nanoscience & nanotechnology01 natural sciences0104 chemical sciencesComputational physicsLength measurementSemiconductorThin film0210 nano-technologybusinessExcitation
researchProduct

Potential and energy of some spheroidal charge distributions with azimuthal symmetry

1989

Abstract The Poisson equation is solved for three types of spheroidal charge distributions with azimuthal symmetry, namely, those depending on one cartesian coordinate, on the radial cylindrical coordinate and on the radial spherical coordinate. The energy of such distributions is found for the case of power functions of these coordinates and it has been normalized, computed and plotted for some low values of the exponent.

PhysicsCurvilinear coordinatesBipolar cylindrical coordinatesMathematical analysisSpherical coordinate systemProlate spheroidal coordinatesCondensed Matter PhysicsSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsClassical mechanicsCylindrical coordinate systemElectrical and Electronic EngineeringElliptic cylindrical coordinatesPoisson's equationBiotechnologyElliptic coordinate systemJournal of Electrostatics
researchProduct